Product Information
HUMALOG 100 UNIT/ML CARTRIDGE is a brand product labeled by Eli Lilly and Company, priced at $9.7856 per ML under NDC 00002751659. Its NADAC has been published 671 times since Nov 28, 2013.
Strength
100 [iU]/mL
Manufacturer
Eli Lilly and CompanyNDC
00002751659
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA020563On Market Since
2/20/1998
Pharmacological Classes
Price Statistics
The NADAC for HUMALOG 100 UNIT/ML CARTRIDGE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 47.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7856 per ML |
|---|---|
| All-time high | $32.6846 (Sep 11, 2019) |
| All-time low | $9.7683 (Dec 17, 2025) |
| 52-week high | $9.7890 |
| 52-week low | $9.7683 |
| Median price | $32.4809 |
| Average price | $25.8901 |
| Largest weekly change | -70.0% (Jan 10, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 75% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eli Lilly and Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Insulin lispro market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HUMALOG 100 UNIT/ML CARTRIDGE?
The current National Average Drug Acquisition Cost (NADAC) for HUMALOG 100 UNIT/ML CARTRIDGE, manufactured by Eli Lilly and Company, is $9.7856 per ML (NDC 00002751659), effective Sep 30, 2026.
How has the price of HUMALOG 100 UNIT/ML CARTRIDGE changed over time?
Over the history we have for it, the NADAC for HUMALOG 100 UNIT/ML CARTRIDGE has declined 47.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HUMALOG 100 UNIT/ML CARTRIDGE?
Since Nov 28, 2013, the NADAC for HUMALOG 100 UNIT/ML CARTRIDGE has ranged from a low of $9.7683 (Dec 17, 2025) to a high of $32.6846 (Sep 11, 2019), with a median of $32.4809 per ML.
Are there cheaper alternatives to HUMALOG 100 UNIT/ML CARTRIDGE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INSULIN LISPRO 100 UNIT/ML VL, is $2.4026 per ML — about 75% below HUMALOG 100 UNIT/ML CARTRIDGE.
Who manufactures HUMALOG 100 UNIT/ML CARTRIDGE?
HUMALOG 100 UNIT/ML CARTRIDGE (NDC 00002751659) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.